![]() | ![]() |
Formats:
|
||||||||||||||||
Copyright © 2009 by The National Academy of Sciences of the USA Genetics A network biology approach to aging in yeast The Howard Hughes Medical Institute, Bioinformatics Program, Center for BioDynamics, Center for Advanced Biotechnology and Department of Biomedical Engineering. Boston University, 44 Cummington Street, Boston, MA 02215 1To whom correspondence may be addressed. E-mail: jcollins/at/bu.edu or Email: ccantor/at/sequenom.com Contributed by Charles R. Cantor, December 9, 2008 .Author contributions: D.R.L., C.R.C., and J.J.C. designed research; D.R.L. performed research; D.R.L. and J.J.C. contributed new reagents/analytic tools; D.R.L. analyzed data; and D.R.L., C.R.C., and J.J.C. wrote the paper. Received November 21, 2008. Freely available online through the PNAS open access option. This article has been cited by other articles in PMC.Abstract In this study, a reverse-engineering strategy was used to infer and analyze the structure and function of an aging and glucose repressed gene regulatory network in the budding yeast Saccharomyces cerevisiae. The method uses transcriptional perturbations to model the functional interactions between genes as a system of first-order ordinary differential equations. The resulting network model correctly identified the known interactions of key regulators in a 10-gene network from the Snf1 signaling pathway, which is required for expression of glucose-repressed genes upon calorie restriction. The majority of interactions predicted by the network model were confirmed using promoter-reporter gene fusions in gene-deletion mutants and chromatin immunoprecipitation experiments, revealing a more complex network architecture than previously appreciated. The reverse-engineered network model also predicted an unexpected role for transcriptional regulation of the SNF1 gene by hexose kinase enzyme/transcriptional repressor Hxk2, Mediator subunit Med8, and transcriptional repressor Mig1. These interactions were validated experimentally and used to design new experiments demonstrating Snf1 and its transcriptional regulators Hxk2 and Mig1 as modulators of chronological lifespan. This work demonstrates the value of using network inference methods to identify and characterize the regulators of complex phenotypes, such as aging. Keywords: chronological aging, gene networks, Snf1 pathway, systems biology Characterizing biomolecular interaction networks can shed new insight into biological processes, including the complex mechanisms regulating longevity and aging. Organisms like the budding yeast Saccharomyces cerevisiae have become valuable model systems to discover genes modulating longevity and to identify their associated interaction networks, many of which are conserved in metazoans (1, 2). Replicative lifespan (RLS), the number of daughter cells an individual mother can produce before senescence, and chronological lifespan (CLS), the length of time cells from stationary phase cultures can remain viable in a quiescent state, are two definitions of yeast age that have achieved common acceptance (1, 3). RLS and CLS have been proposed as models for mitotically active and postmitotic metazoan cells, respectively (1, 3). Longevity extension in response to calorie restriction has been observed in organisms ranging from yeasts to mammals (1, 2, 4) and can be observed in S. cerevisiae by limiting the glucose concentration in the growth medium (2, 5). Consequently, many longevity genes have been identified by their role in relevant cellular processes, such as glucose signaling (5–9). Identifying these genes and growth conditions is a first step in understanding the mechanisms linking aging and calorie restriction. Defining the network of regulatory interactions between these genes could further our understanding of the processes that underlie aging. The development of methods to characterize biomolecular networks has been an active area of research (10–18). Recently, we developed an integrated experimental/computational reverse-engineering strategy, network identification by regression (NIR) (19), for the elucidation of gene regulatory networks. In the present study, we applied this method to 10 genes selected from the glucose-responsive Snf1 pathway (Fig. 1
The NIR method uses mRNA expression changes that arise in response to network gene perturbations (applied here as small, second copy over-expressions) to formulate a first-order network model, which provides a quantitative, directed, and unsupervised description of functional transcriptional interactions. We previously applied the NIR method to a nine-gene subnetwork of the SOS DNA damage response pathway in Escherichia coli (19). Here, we investigate the utility of this approach in a eukaryotic organism using the known interactions of the Snf1 gene regulatory network as an initial benchmark. Results mRNA Expression Profiling and Network Inference. Expression changes in response to ≈2- to 4-fold over-expression of each network gene were profiled using strains containing an integrated second copy of each gene under the control of a doxycycline-inducible promoter (26). After induction, cultures were grown overnight in 2% glucose synthetic media to OD600 ≤ 0.5, which maintained cells in log phase at transcriptional steady-state conditions. Real-time quantitative RT-PCR (qRT-PCR) was used to assay mRNA expression changes relative to an isogenic control strain expressing GFP (Tables S2–S4). GFP mRNA levels in control cultures were measured as an indicator of perturbation size. Expression changes in response to these perturbations were nearly all less than 2-fold relative to control (Fig. 2
To infer the Snf1 gene regulatory network, expression changes less than the propagated standard error were first filtered from the dataset. This significance threshold was chosen based on the 12 replicate RT-PCR reactions for each gene in each perturbation and control strain and the small magnitude of most expression changes. The optimal model recovered from this analysis (Fig. 2 We compared evidence from the literature (summarized in Table S10) with our network model to determine the sensitivity (the percentage of known interactions the NIR model successfully identified) and precision (the percentage of predicted interactions that are consistent with known interactions) of the NIR algorithm, which were found to be 65% and 22%, respectively. Correctly identified known interactions between Snf1 and its targets contributed largely to the sensitivity measure. However, the NIR model also predicted many interactions with no previous literature evidence. The highest proportion of these were observed as input predictions for SNF1 complex subunits SNF1, SNF4, and SIP2, whose regulatory roles have been well-characterized (21) but whose transcriptional regulation has not been previously detailed. We therefore performed additional experiments to test and validate these predicted interactions, as described below. Experimental Verification of Network Model Predictions. In predicted functional interactions, a putative regulator affects the expression of its target through one or more intermediaries. These were tested using deletion strains for each network gene (except MED8, whose deletion mutant is inviable), transformed with plasmid shuttle vectors containing the promoter region from each potential target cloned in-frame with the lacZ reporter gene. ß-galactosidase (ß-gal) activity for each possible target promoter-lacZ plasmid/regulator gene deletion pair was compared to activity from the same plasmid construct in the isogenic wild-type strain. These experiments were performed with cultures grown in both 2% and 0.05% glucose, as some NIR model predictions were observed for regulators previously characterized to be active either during calorie restriction or in both conditions. Fig. 3
In vivo TF-promoter binding for the repressor Mig1 (10) and the gluconeogenic activators Cat8 (29) and Sip4 (10) has been observed by chromatin immunoprecipitation/DNA microarrays (ChIP-chip) and other experimental methods (see Table S1). Hxk2 and Med8 were previously identified with Mig1 as physical repressors of SUC2 expression (24, 25), and Med8 as a repressor of HXK2, binding cis-regulatory sequences within its coding region (24). We used ChIP with detection by real-time quantitative PCR (ChIP-qPCR) to test for Hxk2 and Med8 binding to the promoters [≈350 base pairs (bp) before the ATG start codon] and downstream regions (≈300 bp after the start codon) of all network genes for cells grown in both 2% and 0.05% glucose. These experiments enabled us to test the NIR network model predictions for the essential Med8 protein, and to ascertain whether Hxk2 acts as a TF for network genes other than SUC2. ChIP-qPCR results revealed that Med8 and Hxk2 bind in varying combinations to regulatory regions of all network genes in a statistically significant manner (Fig. 3 Compared to our experimental data (in both 2% and 0.05% glucose culture growth) and literature evidence (Table S19), the NIR network model showed 62% sensitivity and 69% precision. False-positive interactions contributing to the precision result may be a result of posttranscriptional influences predicted in the NIR model that are not identified by measuring promoter-lacZ fusion expression. This type of regulation has been reported for other glucose-repressed genes (7, 32). Of the interactions predicted by NIR, 24% had the opposite sign; that is, a repressing influence was predicted when an activating influence was indicated by experiments, or vice versa. The majority (9 of 16) of these were TF Hxk2 and Mig1 interactions. As an additional means of assessing performance, we performed a permutation test with models generated from 10,000 iterations of NIR using randomized expression data. The true NIR model had higher measures of sensitivity and precision than 88% and 98% of the randomized models, respectively (Fig. S2). Thus, our results show that the NIR algorithm infers the Snf1 gene regulatory network with a high degree of sensitivity, precision and significance. Regulation of SNF1 Gene Expression and its Effect on Chronological Lifespan. The NIR network model predicted that Med8, Hxk2, Snf1, and Mig1 have the largest effects on SNF1 gene expression. ChIP-qPCR data further confirmed Med8 and Hxk2 as direct regulators of SNF1, with higher affinity to downstream than upstream regions for both regulators. In previous studies, SNF1 gene expression was insensitive to growth on a nonfermentable carbon source (33) and increased only slightly during the diauxic shift (6, 34). However, we observed consistent reductions in log-phase growth rate in response to modest levels of SNF1 overexpression during perturbation expression profiling (a doubling time of 1.70 h−1 vs. 1.46 h−1 for the GFP overexpression control strain; P < 0.01), suggesting that small changes in SNF1 mRNA levels are physiologically important. Hxk2 functions as both a glycolytic enzyme and a transcriptional regulator; consequently, a clear definition of its role in glucose signaling has remained elusive (9, 24, 27). Because Snf1 is required for release from glucose repression, and Hxk2 was confirmed as a direct regulator of SNF1, we carried out additional experiments to clarify its role in SNF1 transcriptional control (see hypothesized schematic in Fig. 4
We first tested if putative Med8 and Mig1 cis-regulatory elements in the SNF1 coding region affected expression of SNF1-reporter gene constructs. Motifs with close similarity to the known Med8 binding sequence (24) were identified at + 247, +305, and + 377 nucleotides (nts) past the ATG start codon. Inclusion of the + 305 motif significantly decreased ß-gal activity compared to a SNF1-lacZ fusion construct truncated at + 285 nts (Fig. 4 We next applied knowledge of the interaction network governing SNF1 expression to examine its regulators' influence on CLS. Increased Snf1 activity, through deletion of repressor subunit SIP2 or forced overexpression of the SNF1 gene, has been previously shown to decrease RLS (22). We tested whether Snf1 similarly affects CLS using overexpression strains from perturbation experiments grown in synthetic CLS media (3) containing 2% glucose. CLS was determined from CFUs from aliquots after cultures reached stationary phase. SNF1 over-expression caused a marked decrease in CLS compared to the GFP-expressing control strain (Fig. 4 Discussion In this study we show that the NIR reverse-engineering strategy (19) can be successfully applied to infer gene regulatory networks in eukaryotic organisms. We assessed the performance of the method by comparing the NIR-inferred Snf1 network model to interactions previously described in the literature, which suggested that many interactions with no previous literature evidence were predicted by the model. The majority of these interactions were validated in experiments employing promoter-lacZ fusion constructs in gene deletion strains and ChIP-qPCR assays for physical targets of the Med8 and Hxk2 TFs. The NIR model showed good measures for sensitivity and precision, as compared with confirmation experiments and known literature interactions, and revealed a greater degree of complexity between regulators in the network than previously appreciated. An equally important assessment of a network-identification method is the utility of the inferred model to suggest biologically meaningful, testable hypotheses for phenotype regulation. We focused on the NIR-predicted transcriptional regulation of SNF1 by Hxk2, Med8, and Mig1, and confirmed Hxk2 and Med8 as direct regulators and Mig1 as an indirect regulator of SNF1 expression in 2% glucose growth. Hxk2 and Med8 were also found to repress CAT8, a major activator of gluconeogenic genes (7, 29). These results suggest a glucose-responsive signaling mechanism for Hxk2 worthy of further study, given the previously reported challenges in clarifying its downstream targets (9, 24, 27). We also showed that SNF1 up-regulation reduces CLS, and knowledge of the network architecture governing SNF1 expression led to the identification of Hxk2 and Mig1 as synergistic but not individual modulators of CLS. Because the HXK2 and MIG1 single-deletion mutants caused no change in CLS, it is unlikely that these two modulators of CLS would be identified without knowledge of the gene regulatory network architecture. The sequence, function, and regulatory interactions of Hxk2, Med8, and Snf1/AMP kinase are highly conserved among eukaryotes (21, 24, 28), and therefore, these results may have implications for understanding the role of AMP kinase in regulating metazoan organism lifespan (1). Materials and Methods Strains and Culture Growth. Strains for network inference were constructed in the W303-dervied parent BMA64–1A (MATa ura3–1 ade2–1 leu2–3, 112 his3–11, 15 trp1Δ can1–100) using a tetracycline-inducible expression system (both were obtained from the EUROSCARF repository). Plasmid pCM252 (26) from this set was modified for chromosomal integration at the his3 auxotrophic marker. Network gene ORFs or yeast-enhanced GFP were PCR cloned into this vector, which was transformed into BMA64–1A. For ß-gal assay strains, network gene promoters (–1,000 to + 18 bp relative to the start codon, except when noted) were PCR cloned in-frame with the lacZ gene in YEp356R and YEp357 shuttle vectors (purchased from the American Type Culture Collection or ATCC), and transformed into Saccharomyces Gene Deletion Project strains and isogenic parent BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0) (Invitrogen). ChIP strains were constructed in BY4742 by tagging the 3′ termini of HXK2 and MED8 genes with the 13-Myc epitope (35). The hxk2Δmig1Δ strain was constructed by replacement of HXK2 with the LEU2 gene amplified from pRS305 (ATCC) in the mig1Δ deletion strain. See SI Materials and Methods for details. Cells were cultured at 30 °C with shaking at 300 RPM in the appropriate selective synthetic complete (SC) dropout media (Sigma), except for ChIP experiments performed in YPD (36). For network inference experiments, saturated overnight (o/n) cultures diluted ≈1/400 in fresh media were grown 8 h to OD600 ≈ 0.2 to 0.5, then diluted again in media containing doxycycline and grown 14 h to OD600 ≈ 0.5 for RNA extraction. Perturbation and GFP strains were cultured concurrently in quadruplicate for each experiment. Doxycycline concentration was varied from 0.8 to 3 μg/ml to induce over-expression from 2- to 4-fold, based upon estimated basal expression of the endogenous gene. For confirmation experiments in 2% glucose, saturated o/n cultures were diluted in fresh media to obtain OD600 ≈ 0.8 to 1.0 cultures after 5 to 6 h growth. Calorie restriction experiments used cultures pregrown in 2% glucose 4 h to OD600 ≈ 0.5, which were then washed and resuspended in 0.05% glucose media and grown 4 to 5 h to OD600 ≈ 0.8–1.0. Network Inference Approach. The NIR system-identification method (19) models the regulatory interactions between transcripts as a system of ordinary differential equations describing the rate of accumulation of each network species as a weighted sum of the quantity of other species in the network:
qRT-PCR mRNA Expression Profiling. RNA was extracted using an acid phenol method, then treated with DNA-Free RNase-free DNase (Ambion). Reverse transcription of normalized total RNA and qPCR were performed using TaqMan and SYBR Green reagents (Applied Biosystems) according to the manufacturer's instructions. See SI Materials and Methods for details. ß-Galactosidase Assays. All experiments used 3 to 5 cultures grown from fresh transformations of promoter-lacZ fusion plasmids into the gene-deletion strain of interest and control strain BY4742. Control and experimental strains were grown concurrently using identical media. β-gal activity was determined with the Yeast β-Galactosidase Assay Kit (Pierce Biotechnology), according to the manufacturer's instructions. ChIP-qPCR Analysis. Three biological replicates from epitope-tagged Hxk2 and Med8 and isogenic wild-type strain BY4742 were grown and processed in parallel. ChIP was performed as previously described (10), with minor alterations detailed in SI Materials and Methods. Following final DNA extraction and purification, qPCR was used to detect significant enrichment (P ≤ 0.10) of network gene promoter and coding region DNA in immunoprecipitates from tagged strains compared to wild-type (See SI Materials and Methods). Chronological Lifespan Assays. CLS experiments were performed in standard recipe SC media (36) supplemented with a 4-fold excess of each parent strains' auxotrophic nutrients (Uracil, Adenine, Leu, His and Trp for BMA64–1A; Uracil, Leu, His and Lys for BY4742) (3). Triplicate CLS cultures were grown from 60-μl saturated o/n cultures inoculated into 6.0 ml of the appropriate SC media maintained at 30 °C, 300 RPM in 14-ml tubes. SNF1 and GFP over-expression strains were induced with 1.0-μg/ml doxycycline. We then removed 100-μl aliquots of CLS cultures at the indicated timepoints in Fig. 4 Numerics. NIR algorithm computations and data analysis were performed using MATLAB v7.4 (The Mathworks). Statistical analyses and outlier determination for data are detailed in SI Materials and Methods. All P values were calculated using Student's t test (unpaired, heteroscedastic), unless otherwise noted. Supporting Information
Acknowledgments. We thank Gábor Balázsi, William J. Blake, and Michael J. Thompson for helpful discussions with experimental design and analysis, and Joseph F. Ryan for comments on the manuscript. This work was supported by the Ellison Medical Foundation, the National Institutes of Health through the National Institutes of Health Director's Pioneer Award Program, Grant DP1 OD003644, and the Howard Hughes Medical Institute. Footnotes The authors declare no conflict of interest. This article contains supporting information online at www.pnas.org/cgi/content/full/0812551106/DCSupplemental. References 1. Bishop NA, Guarente L. Genetic links between diet and lifespan: shared mechanisms from yeast to humans. Nat Rev Genet. 2007;8:835–844. [PubMed] 2. Kaeberlein M, Burtner C, Kennedy B. Recent developments in yeast aging. PLoS Genet. 2007;3:e84. [PubMed] 3. Fabrizio P, Longo VD. The chronological life span of Saccharomyces cerevisiae. Aging Cell. 2003;2:73–81. [PubMed] 4. Bitterman KJ, Medvedik O, Sinclair D. Longevity regulation in Saccharomyces cerevisiae: linking metabolism, genome stability, and heterochromatin. Microbiol Mol Biol Rev. 2003;67:376–399. [PubMed] 5. Lin SJ, Defossez PA, Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science. 2000;289:2126–2128. [PubMed] 6. DeRisi JL, Iyer VR, Brown PO. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science. 1997;278:680–686. [PubMed] 7. Schüller HJ. Transcriptional control of nonfermentative metabolism in the yeast Saccharomyces cerevisiae. Curr Genet. 2003;43:139–160. [PubMed] 8. Kaeberlein M, Kirkland KT, Fields S, Kennedy BK. Genes determining yeast replicative life span in a long-lived genetic background. Mech Ageing Devt. 2005;126:491–504. 9. Santangelo GM. Glucose signaling in Saccharomyces cerevisiae. Microbiol Mol Biol Rev. 2006;70:253–282. [PubMed] 10. Lee TI, et al. Transcriptional regulatory networks in Saccharomyces cerevisiae. Science. 2002;298:799–804. [PubMed] 11. Yeung MK, Tegnér J, Collins JJ. Reverse engineering gene networks using singular value decomposition and robust regression. Proc Natl Acad Sci USA. 2002;99:6163–6168. [PubMed] 12. Tegner J, Yeung MK, Hasty J, Collins JJ. Reverse engineering gene networks: integrating genetic perturbations with dynamical modeling. Proc Natl Acad Sci USA. 2003;100:5944–5949. [PubMed] 13. Basso K, et al. Reverse engineering of regulatory networks in human B cells. Nat Genet. 2005;37:382–390. [PubMed] 14. di Bernardo D, et al. Chemogenomic profiling on a genome-wide scale using reverse-engineered gene networks. Nat Biotechnol. 2005;23:377–383. [PubMed] 15. Bonneau R, et al. The Inferelator: an algorithm for learning parsimonious regulatory networks from systems-biology data sets de novo. Genome Biol. 2006;7:R36. [PubMed] 16. Workman CT, et al. A systems approach to mapping DNA damage response pathways. Science. 2006;312:1054–1059. [PubMed] 17. Faith J, et al. Large-scale mapping and validation of Escherichia coli transcriptional regulation from a compendium of expression profiles. Plos Biol. 2007;5:e8. [PubMed] 18. Lee I, Li Z, Marcotte E. An improved, bias-reduced probabilistic functional gene network of baker's yeast, Saccharomyces cerevisiae. PLoS ONE. 2007;2:e988. [PubMed] 19. Gardner TS, di Bernardo D, Lorenz D, Collins JJ. Inferring genetic networks and identifying compound mode of action via expression profiling. Science. 2003;301:102–105. [PubMed] 20. Celenza JL, Carlson M. A yeast gene that is essential for release from glucose repression encodes a protein kinase. Science. 1986;233:1175–1180. [PubMed] 21. Hedbacker K, Carlson M. SNF1/AMPK pathways in yeast. Front Biosci. 2008;13:2408–2420. [PubMed] 22. Ashrafi K, Lin SS, Manchester JK, Gordon JI. Sip2p and its partner Snf1p kinase affect aging in S. cerevisiae. Genes Dev. 2000;14:1872–1885. [PubMed] 23. Harkness TA, Shea KA, Legrand C, Brahmania M, Davies GF. A functional analysis reveals dependence on the anaphase-promoting complex for prolonged life span in yeast. Genetics. 2004;168:759–774. [PubMed] 24. Moreno F, Herrero P. The hexokinase 2-dependent glucose signal transduction pathway of Saccharomyces cerevisiae. FEMS Microbiol Rev. 2002;26:83–90. [PubMed] 25. Moreno F, Ahuatzi D, Riera A, Palomino CA, Herrero P. Glucose sensing through the Hxk2-dependent signalling pathway. Biochem Soc Trans. 2005;33:265–268. [PubMed] 26. Bellí G, Garí E, Piedrafita L, Aldea M, Herrero E. An activator/repressor dual system allows tight tetracycline-regulated gene expression in budding yeast. Nucleic Acids Res. 1998;26:942–947. [PubMed] 27. Bisson LF, Kunathigan V. On the trail of an elusive flux sensor. Res Microbiol. 2003;154:603–610. [PubMed] 28. Casamassimi A, Napoli C. Mediator complexes and eukaryotic transcription regulation: an overview. Biochimie. 2007;89:1439–1446. [PubMed] 29. Tachibana C, et al. Combined global localization analysis and transcriptome data identify genes that are directly coregulated by Adr1 and Cat8. Mol Cell Biol. 2005;25:2138–2146. [PubMed] 30. Palomino A, Herrero P, Moreno F. Tpk3 and Snf1 protein kinases regulate Rgt1 association with Saccharomyces cerevisiae HXK2 promoter. Nucleic Acids Res. 2006;34:1427–1438. [PubMed] 31. Zhu X, et al. Genome-wide occupancy profile of mediator and the Srb8–11 module reveals interactions with coding regions. Mol Cell. 2006;22:169–178. [PubMed] 32. Bennett MR, et al. Metabolic gene regulation in a dynamically changing environment. Nature. 2008;454:1119–1122. [PubMed] 33. Celenza JL, Carlson M. Structure and expression of the SNF1 gene of Saccharomyces cerevisiae. Mol Cell Biol. 1984;4:54–60. [PubMed] 34. Chang YW, et al. Roles of cis- and trans-changes in the regulatory evolution of genes in the gluconeogenic pathway in yeast. Mol Biol Evol. 2008;25:1863–1875. [PubMed] 35. Longtine MS, et al. Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast. 1998;14:953–961. [PubMed] 36. Burke D, Dawson D, Stearns T. Methods in Yeast Genetics. Woodbury, NY: Cold Spring Harbor Laboratory Press; 2000. |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Nat Rev Genet. 2007 Nov; 8(11):835-44.
[Nat Rev Genet. 2007]PLoS Genet. 2007 May 25; 3(5):e84.
[PLoS Genet. 2007]Aging Cell. 2003 Apr; 2(2):73-81.
[Aging Cell. 2003]Nat Rev Genet. 2007 Nov; 8(11):835-44.
[Nat Rev Genet. 2007]PLoS Genet. 2007 May 25; 3(5):e84.
[PLoS Genet. 2007]Microbiol Mol Biol Rev. 2003 Sep; 67(3):376-99, table of contents.
[Microbiol Mol Biol Rev. 2003]Science. 2000 Sep 22; 289(5487):2126-8.
[Science. 2000]Science. 1997 Oct 24; 278(5338):680-6.
[Science. 1997]Science. 2002 Oct 25; 298(5594):799-804.
[Science. 2002]Proc Natl Acad Sci U S A. 2002 Apr 30; 99(9):6163-8.
[Proc Natl Acad Sci U S A. 2002]Proc Natl Acad Sci U S A. 2003 May 13; 100(10):5944-9.
[Proc Natl Acad Sci U S A. 2003]Nat Genet. 2005 Apr; 37(4):382-90.
[Nat Genet. 2005]Nat Biotechnol. 2005 Mar; 23(3):377-83.
[Nat Biotechnol. 2005]Science. 2003 Jul 4; 301(5629):102-5.
[Science. 2003]Nucleic Acids Res. 1998 Feb 15; 26(4):942-7.
[Nucleic Acids Res. 1998]Front Biosci. 2008 Jan 1; 13():2408-20.
[Front Biosci. 2008]Curr Genet. 2003 Jun; 43(3):139-60.
[Curr Genet. 2003]Curr Genet. 2003 Jun; 43(3):139-60.
[Curr Genet. 2003]Microbiol Mol Biol Rev. 2006 Mar; 70(1):253-82.
[Microbiol Mol Biol Rev. 2006]Front Biosci. 2008 Jan 1; 13():2408-20.
[Front Biosci. 2008]Res Microbiol. 2003 Nov; 154(9):603-10.
[Res Microbiol. 2003]Biochimie. 2007 Dec; 89(12):1439-46.
[Biochimie. 2007]Front Biosci. 2008 Jan 1; 13():2408-20.
[Front Biosci. 2008]Science. 2002 Oct 25; 298(5594):799-804.
[Science. 2002]Mol Cell Biol. 2005 Mar; 25(6):2138-46.
[Mol Cell Biol. 2005]FEMS Microbiol Rev. 2002 Mar; 26(1):83-90.
[FEMS Microbiol Rev. 2002]Biochem Soc Trans. 2005 Feb; 33(Pt 1):265-8.
[Biochem Soc Trans. 2005]Biochimie. 2007 Dec; 89(12):1439-46.
[Biochimie. 2007]Nucleic Acids Res. 2006; 34(5):1427-38.
[Nucleic Acids Res. 2006]Mol Cell. 2006 Apr 21; 22(2):169-78.
[Mol Cell. 2006]Biochem Soc Trans. 2005 Feb; 33(Pt 1):265-8.
[Biochem Soc Trans. 2005]Curr Genet. 2003 Jun; 43(3):139-60.
[Curr Genet. 2003]Nature. 2008 Aug 28; 454(7208):1119-22.
[Nature. 2008]Mol Cell Biol. 1984 Jan; 4(1):54-60.
[Mol Cell Biol. 1984]Science. 1997 Oct 24; 278(5338):680-6.
[Science. 1997]Mol Biol Evol. 2008 Sep; 25(9):1863-75.
[Mol Biol Evol. 2008]Microbiol Mol Biol Rev. 2006 Mar; 70(1):253-82.
[Microbiol Mol Biol Rev. 2006]FEMS Microbiol Rev. 2002 Mar; 26(1):83-90.
[FEMS Microbiol Rev. 2002]FEMS Microbiol Rev. 2002 Mar; 26(1):83-90.
[FEMS Microbiol Rev. 2002]Curr Genet. 2003 Jun; 43(3):139-60.
[Curr Genet. 2003]Mol Biol Evol. 2008 Sep; 25(9):1863-75.
[Mol Biol Evol. 2008]Biochem Soc Trans. 2005 Feb; 33(Pt 1):265-8.
[Biochem Soc Trans. 2005]Genes Dev. 2000 Aug 1; 14(15):1872-85.
[Genes Dev. 2000]Aging Cell. 2003 Apr; 2(2):73-81.
[Aging Cell. 2003]Science. 2003 Jul 4; 301(5629):102-5.
[Science. 2003]Curr Genet. 2003 Jun; 43(3):139-60.
[Curr Genet. 2003]Mol Cell Biol. 2005 Mar; 25(6):2138-46.
[Mol Cell Biol. 2005]Microbiol Mol Biol Rev. 2006 Mar; 70(1):253-82.
[Microbiol Mol Biol Rev. 2006]FEMS Microbiol Rev. 2002 Mar; 26(1):83-90.
[FEMS Microbiol Rev. 2002]Res Microbiol. 2003 Nov; 154(9):603-10.
[Res Microbiol. 2003]Front Biosci. 2008 Jan 1; 13():2408-20.
[Front Biosci. 2008]FEMS Microbiol Rev. 2002 Mar; 26(1):83-90.
[FEMS Microbiol Rev. 2002]Biochimie. 2007 Dec; 89(12):1439-46.
[Biochimie. 2007]Nat Rev Genet. 2007 Nov; 8(11):835-44.
[Nat Rev Genet. 2007]Nucleic Acids Res. 1998 Feb 15; 26(4):942-7.
[Nucleic Acids Res. 1998]Yeast. 1998 Jul; 14(10):953-61.
[Yeast. 1998]Science. 2003 Jul 4; 301(5629):102-5.
[Science. 2003]Science. 2002 Oct 25; 298(5594):799-804.
[Science. 2002]Aging Cell. 2003 Apr; 2(2):73-81.
[Aging Cell. 2003]